Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,148 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05048251Recruiting
Targeted brain stimulation for OCD with contamination symptoms
This study tests a personalized brain-stimulation approach to help people with obsessive-compulsive disorder (OCD) focused on contamination worries. If you have the “contamination” type of OCD and meet the safety and medication rules, you may be able to join and see whether this targeted treatment reduces symptoms.
Belmont, MassachusettsAges 18–55 - NCT06215495Recruiting
New radiation target method for high-grade glioma
This study is testing a new way to target radiation for people with high-grade gliomas (aggressive brain tumors). The goal is to see if a more precise treatment plan can improve outcomes while keeping side effects low.
GuangzhouAges 18–65 - NCT06037733Recruiting
Focused radiation to main tumor after chemo-immunotherapy for lung cancer
This trial is for people with advanced non-small cell lung cancer whose tumors responded well to initial chemo-immunotherapy. Instead of giving full chest radiation, doctors will only target the main tumor to see if it can prevent regrowth with fewer side effects.
Wuhan, HubeiAges 18–75 - NCT06268262Recruiting
Obesity brain imaging study before and after surgery
This study uses brain scans to understand how obesity affects the brain and how bariatric surgery may change it. It compares people with obesity who are planning surgery to healthy volunteers.
Xuzhou, JiangsuAges 18–65 - NCT06032052RecruitingPhase 2
Chemo plus immunotherapy for older adults with metastatic lung cancer
This trial tests a combination of chemotherapy and immunotherapy for people 65 or older with metastatic non-small cell lung cancer that has not been treated before and expresses PD-L1. It aims to see if this treatment can help control the cancer.
Wuhan, HubeiAges 65 years+ - NCT06020430Recruiting
Skipping routine radiation for advanced lung cancer after immunotherapy and chemo
This trial tests whether it is safe to skip routine radiation to the tumor bed in patients with stage III lung cancer that has responded well to immunotherapy and chemotherapy. It aims to reduce side effects while still controlling the cancer.
Wuhan, HubeiAges 18–75 - NCT06313463RecruitingPhase 3
Capecitabine and camrelizumab for TNBC after chemotherapy
This trial tests if combining the chemotherapy pill capecitabine with the immunotherapy drug camrelizumab can help people with triple-negative breast cancer (TNBC) who still have tumor tissue after initial treatment. It is for patients whose breast cancer has structures called tumor-associated lymphoid structures (TLS) and who did not achieve a complete response to neoadjuvant therapy.
Guangzhou, GuangdongAges 18–80 - NCT06276088Recruiting
SAA1 levels to predict cancer immunotherapy response
This trial measures a protein called SAA1 in your blood and tumor tissue to see if it can predict how your cancer will respond to immunotherapy. It aims to understand why some patients have rapid tumor growth after treatment.
Guangzhou, GuangdongAges 18 years+ - NCT06302634Recruiting
Heart rehab program for cancer patients at risk
This trial tests a rehabilitation program designed to help people at high risk of heart problems from cancer treatment. You would do exercises and have check-ups, either at the hospital or at home.
Santiago de Compostela, A CoruñaAges 18–70 - NCT05389956Recruiting
Study links health screening results to heart and cancer risk
This study follows people who had a routine health check to learn what increases the risk of heart disease and cancer. Your answers and test results may help doctors better understand risk factors in the Korean population.
UlsanAges 19 years+ - NCT06234007RecruitingPhase 2
Short radiation plus combo therapy for advanced rectal cancer
This trial tests a short course of radiation therapy followed by a combination of three drugs (fruquintinib, adebrelimab, and CAPOX chemotherapy) before surgery for people with locally advanced rectal cancer. The goal is to see if this approach can shrink the tumor and improve outcomes.
WuhanAges 18–75 - NCT06145906Recruiting
Optimizing catheter ablation for atrial fibrillation
This trial is studying a way to improve the entire process of catheter ablation for atrial fibrillation. It may help people who are having this procedure for the first time and have a normal-sized left atrium and good heart function.
Zhengzhou, HenanAges 18–80 - NCT06244914Recruiting
Combined brain stimulation for recovery after recent stroke
This trial tests if combining two kinds of gentle brain stimulation can help people recover better after a recent stroke. It's for people who had a clot-caused stroke in the upper part of the brain and still have some weakness on one side.
Tainan, TainanAges 18 years+ - NCT03644732Recruiting
Study of brain activity during epilepsy testing using SEEG
This study maps how thinking and memory work by recording brain signals during a presurgical epilepsy workup. It may help doctors better understand drug-resistant focal epilepsy and improve how they plan treatment.
GrenobleAges 18–65 - NCT05224518Recruiting
Exercise program to improve quality of life in colorectal cancer
This trial tests whether a structured exercise program can improve quality of life for people with colorectal cancer. You may be asked to complete questionnaires in Mandarin/Taiwanese and follow exercise-related study rules to see if symptoms and daily well-being improve.
HsinchuAges 20 years+ - NCT06090591Recruiting
Heart condition research registry at Dubrava Hospital
This study is a registry that will collect information from people with certain heart conditions (like having a pacemaker, a blood clot, a heart attack, or a valve replacement procedure called TAVI). The goal is to learn more about these conditions and how they are treated.
ZagrebAges 18 years+ - NCT06266715Recruiting
Testing ATP for depression relief
This trial tests if a natural compound called ATP can help improve moderate to severe depression symptoms. If you haven't taken antidepressants recently and have never tried escitalopram, you may be eligible.
Guangzhou, GuangdongAges 18–65 - NCT05883800Recruiting
Total treatment with tailored radiation for advanced rectal cancer
This study tests a “total neoadjuvant” approach—chemotherapy first, then radiation—using adaptive (tailored) radiation planning for people with locally advanced rectal cancer. It may help improve tumor control while adjusting the radiation based on how your cancer and anatomy respond.
BergenAges 18 years+ - NCT06320600Recruiting
Precision Diabetes Medicine Program in China
This study is looking for people who have been recently diagnosed with diabetes (within the past year) to help find the best treatments for each person's unique needs. It is part of a national program in China to personalize diabetes care.
Changsha, HunanAges Any age - NCT06319157Recruiting
Minimal access vs. standard back muscle flap for breast reconstruction
This study compares a less invasive method of harvesting the latissimus dorsi (a back muscle) for breast reconstruction. It is for early-stage breast cancer patients who have mild to moderate breast sagging and want to use their own tissue for reconstruction.
Guangzhou, GuangdongAges 18–70 - NCT04905160Recruiting
Care planning after hospital stays to reduce readmissions
This study tests a care-coordination plan to see if it helps people leave the hospital and prevents them from needing to come back soon. It focuses on certain heart-related hospital diagnoses and, for some parts, also includes people with recent COVID-19.
Phoenix, ArizonaAges 18 years+ - NCT06320223Recruiting
PSMA PET scan registry for prostate cancer outcomes
This registry collects information from people with prostate cancer who have had a PSMA PET scan. Researchers want to learn how well this scan predicts outcomes over at least 3 years, which may help improve future care.
EssenAges 18 years+ - NCT06321939Recruiting
Tracking EBV DNA in Blood for Nasopharyngeal Cancer
This trial studies whether tracking levels of Epstein-Barr virus DNA in your blood can help guide treatment for non-metastatic nasopharyngeal cancer. You would get standard radiation and maybe chemotherapy, with extra blood tests to see how the virus levels change.
Changsha, HunanAges 18 years+ - NCT06250023Recruiting
Oral antibiotics for spinal infection treatment
This trial tests whether oral antibiotics, taken as pills, work as well as IV antibiotics for treating spinal infections. It may be an option if your infection is already improving with a short course of IV antibiotics.
CopenhagenAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,148 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.